Straits Times Index
3,337.86 +5.06 (+0.15%) Nikkei
39,584.42 +1.34 (+0.00%) Hang Seng
17,718.61 +2.11 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
63,201.38 +2,513.35 (+4.14%) CMC Crypto 200
1,311.32 +27.49 (+2.14%)
Ono Pharmaceutical Co., Ltd. (4528.T)
| Previous close | 2,196.50 |
| Open | 2,211.00 |
| Bid | 2,210.00 x 0 |
| Ask | 2,210.00 x 0 |
| Day's range | 2,203.50 - 2,224.50 |
| 52-week range | 2,097.50 - 2,966.50 |
| Volume | |
| Avg. volume | 2,114,826 |
| Market cap | 1.038T |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 8.29 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 80.00 (3.64%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
- PR Newswire
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
ONO Pharmaceutical, Co., Ltd., (TSE: 4528, Representative Director, Chairman of the Board and Chief Executive Officer: Gyo Sagara, "ONO") and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH, Chief Executive Officer: Steven L. Hoerter, "Deciphera") today announced that on April 29, 2024 (Japan time), ONO and Deciphera entered into a definitive merger agreement under which ONO will acquire all outstanding shares of Deciphera common stock for US $ 25.60 per share in cash through a tender offer follow
- PR Newswire
Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.
